InvestorsHub Logo
Followers 16
Posts 1267
Boards Moderated 0
Alias Born 01/24/2015

Re: None

Monday, 11/20/2017 8:11:50 PM

Monday, November 20, 2017 8:11:50 PM

Post# of 27120
ACOL might be a, (what did the naysayers call it? Oh yes...) a "slow bleeder" between news releases; but wow these transfusions are doing good keeping it alive until the big runaways coming up can take over. She saw $.05 before, now she's starting from a much higher baseline; let's see what she's got...